First Berlin reiterates Buy on Pharming, keeps EUR 2.2 target price
Bitget2026/09/23 08:57- First Berlin reiterated a Buy rating on Pharming Group, keeping a EUR 2.2 12-month target price.
- Update followed acceptance of an abstract on positive phase 2 leniolisib topline data for PI3KD-linked primary immunodeficiencies.
- Trial results showed improved lymphoproliferative disease, including a 26.4% mean spleen volume reduction.
- Safety profile matched prior experience; infections were most common, with no new safety signals flagged.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pre-orders for GTA 6 are booming and may reverse the downward trend! Citigroup raises Take-Two Interactive Software (TTWO.US) target to $270
Citigroup maintains a "Buy" rating on Take-Two Interactive Software, with a target price of $270.
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Swiss Franc holds ground as US Dollar consolidates ahead of CPI inflation data
Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.
Crypto prices
More
